Kalaris Therapeutics, Inc.
KLRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001754068
No open-market purchases or sales by Kalaris Therapeutics, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q3 2026, worth $49.8M in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in Kalaris Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- −2 vs. Q2 2026
- Shares held
- 17.2M
- −806.6K (−4.5%) vs. Q2 2026
- Total value
- $49.8M
- −$23.6M (−32.2%) vs. Q2 2026
- New holders
- 6
- 13 more added
- Sold out
- 8
- 20 more reduced
1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KLRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 53 | $49.8M |
| Q2 2026 | 56 | $73.4M |
| Q1 2026 | 58 | $107.2M |
| Q4 2025 | 51 | $151.9M |
| Q3 2025 | 32 | $76.4M |
| Q2 2025 | 30 | $35.7M |
| Q1 2025 | 32 | $111.4M |
| Q4 2024 | 53 | $20.7M |
| Q3 2024 | 60 | $36.3M |
| Q2 2024 | 72 | $33.9M |
| Q1 2024 | 77 | $36.4M |
| Q4 2023 | 82 | $28.5M |
| Q3 2023 | 90 | $115.5M |
| Q2 2023 | 94 | $183.6M |
| Q1 2023 | 89 | $156.0M |
| Q4 2022 | 86 | $193.1M |
| Q3 2022 | 87 | $293.7M |
| Q2 2022 | 84 | $109.6M |
| Q1 2022 | 84 | $184.1M |
| Q4 2021 | 84 | $329.4M |
| Q3 2021 | 80 | $640.3M |
| Q2 2021 | 84 | $521.8M |
| Q1 2021 | 75 | $624.4M |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Kalaris Therapeutics, Inc.; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 12,881,175 | $37.2M | 3.54% | 00.0% | Unchanged |
| RTW Investments, LP | 1,300,000 | $3.76M | 0.04% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 472,687 | $1.37M | 0.00% | −100,000−17.5% | Reduced |
| Siren, L.L.C. | 356,559 | $1.03M | 0.02% | −79,239−18.2% | Reduced |
| Vanguard Capital Management LLC | 330,928 | $956.4K | 0.00% | −67,784−17.0% | Reduced |
| Ikarian Capital, LLC | 248,257 | $717.5K | 0.14% | −111,743−31.0% | Reduced |
| Renaissance Technologies LLC | 176,863 | $511.1K | 0.00% | +27,512+18.4% | Added |
| Verdad Advisers, LP | 140,232 | $405.3K | 0.43% | +59,935+74.6% | Added |
| UBS Group AG | 110,187 | $318.4K | 0.00% | −151,944−58.0% | Reduced |
| Raymond James Financial Inc | 101,496 | $293.3K | 0.00% | +4,332+4.5% | Added |
| Whi Trust Co LLC | 97,493 | $281.8K | 0.16% | 00.0% | Unchanged |
| Woodline Partners LP | 90,000 | $260.1K | 0.00% | −10,000−10.0% | Reduced |
| Geode Capital Management, LLC | 78,859 | $228.0K | 0.00% | −35,178−30.8% | Reduced |
| Boothbay Fund Management, LLC | 63,623 | $183.9K | 0.00% | −28,638−31.0% | Reduced |
| ADAR1 Capital Management, LLC | 60,000 | $173.4K | 0.01% | −40,000−40.0% | Reduced |
| BlackRock, Inc. | 58,619 | $169.4K | 0.00% | +4,177+7.7% | Added |
| State Street Corp | 51,210 | $148.0K | 0.00% | +24,700+93.2% | Added |
| Vanguard Fiduciary Trust Co | 47,553 | $137.4K | 0.00% | −18,626−28.1% | Reduced |
| Belpointe Asset Management LLC | 40,000 | $115.6K | 0.00% | 00.0% | Unchanged |
| Fortis Capital Advisors, LLC | 40,000 | $115.6K | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 39,616 | $114.5K | 0.00% | +23,562+146.8% | Added |
| Citadel Advisors LLC | 39,219 | $113.3K | 0.00% | −56,553−59.0% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 35,678 | $103.1K | 0.00% | +5,671+18.9% | Added |
| Stonepine Capital Management, LLC | 33,842 | $97.8K | 0.08% | +3,720+12.3% | Added |
| Morgan Stanley | 26,773 | $77.4K | 0.00% | −45,553−63.0% | Reduced |
| Northern Trust Corp | 25,833 | $74.7K | 0.00% | −60.0% | Reduced |
| HRT Financial LP | 25,560 | $73.0K | 0.00% | +11,837+86.3% | Added |
| Velan Capital Investment Management LP | 25,000 | $72.3K | 0.07% | 00.0% | Unchanged |
| WealthTrust Asset Management, LLC | 23,604 | $68.2K | 0.04% | +3,188+15.6% | Added |
| Quadrature Capital Ltd | 23,287 | $67.3K | 0.00% | +6,760+40.9% | Added |
| Bridgeway Capital Management, LLC | 22,500 | $65.0K | 0.00% | −10,000−30.8% | Reduced |
| Empowered Funds, LLC | 22,500 | $65.0K | 0.00% | +22,500 | New |
| Jane Street Group, LLC | 19,594 | $56.6K | 0.00% | +19,594 | New |
| Squarepoint Ops LLC | 18,947 | $54.8K | 0.00% | −19,828−51.1% | Reduced |
| RBF Capital, LLC | 17,391 | $50.3K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 15,958 | $46.1K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 14,726 | $42.6K | 0.00% | +14,726 | New |
| Nano Cap New Millennium Growth Fund L P | 14,000 | $40.5K | 0.03% | +1,500+12.0% | Added |
| Independent Advisor Alliance | 12,625 | $36.5K | 0.00% | −5,500−30.3% | Reduced |
| FMR LLC | 7,806 | $22.6K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 6,000 | $17.3K | 0.00% | +6,000 | New |
| Nuveen, LLC | 4,639 | $13.5K | 0.00% | +4,639 | New |
| Caitong International Asset Management Co., Ltd | 1,559 | $4.51K | 0.00% | +1,552+22,171.4% | Added |
| Tower Research Capital LLC (TRC) | 838 | $2.42K | 0.00% | −1,722−67.3% | Reduced |
| Vanguard Global Advisers, LLC | 725 | $2.10K | 0.00% | 00.0% | Unchanged |
| Strengthening Families & Communities, LLC | 268 | $775 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 50 | $145 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 46 | $133 | 0.00% | −6−11.5% | Reduced |
| Steward Partners Investment Advisory, LLC | 21 | $61 | 0.00% | −2,194−99.1% | Reduced |
| Barclays PLC | 17 | $49 | 0.00% | −286−94.4% | Reduced |
| Harbour Investments, Inc. | 13 | $38 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 5 | $14 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $3 | 0.00% | +1 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −139,201−100.0% | Sold out |
| Pale Fire Capital SE | 0 | $0 | 0.00% | −39,626−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −29,737−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −23,847−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,221−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,845−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −10,167−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Royal Bank of Canada | – | – | – | – | Not filed |